Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Salgia

Showing results (91-100 of 528) with videos related to

Pageof 53
Sort By:
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 27, 2007
Activation of HGF/c-Met pathway contributes to the reactive oxygen species generation and motility of small cell lung cancer cellsRamasamy Jagadeeswaran, Sujatha Jagadeeswaran, Vytas P Bindokas, et al.
Translational Oncology|June 6, 2026
Engineering nanozymes for cancer theranostics: Chemical design, catalytic intelligence, and translational oncology frontiersPankaj Garg, David Horne, Ravi Salgia, et al.
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|October 13, 2009
MET, HGF, EGFR, and PXN gene copy number in lung cancer using DNA extracts from FFPE archival samples and prognostic significanceRajani Kanteti, Soheil Yala, Mark K Ferguson, et al.
Neurology|January 30, 2013
Teaching Video NeuroImages: myokymia and nerve hyperexcitability as components of Morvan syndrome due to malignant thymomaRimas V Lukas, Kourosh Rezania, Monica Malec, et al.
Future Oncology (London, England)|February 19, 2016
Systemic therapies in the treatment of non-small-cell lung cancer brain metastasesRimas V Lukas, Priya Kumthekar, Syeda Rizvi, et al.
Cancer Metastasis Reviews|July 30, 2003
c-Met: structure, functions and potential for therapeutic inhibitionPatrick C Ma, Gautam Maulik, James Christensen, et al.
Frontiers in Pharmacology|January 24, 2022
Novel Therapeutic Targets and Immune Dysfunction in Malignant Pleural MesotheliomaMoshe Lapidot, Srinivas Vinod Saladi, Ravi Salgia, et al.
Trends in Molecular Medicine|July 23, 2019
The Mitochondrion as an Emerging Therapeutic Target in CancerKatherine G Roth, Isa Mambetsariev, Prakash Kulkarni, et al.
Trends in Cancer|March 2, 2021
Quantifying Cancer: More Than Just a Numbers GameRavi Salgia, Prakash Kulkarni, Herbert Levine, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Tumor Heterogeneity and Therapeutic ResistanceChristine M Lovly, April K S Salama, Ravi Salgia
Pageof 53

Showing results (91-100 of 528) with videos related to

Sort By:
Pageof 53
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 27, 2007
Activation of HGF/c-Met pathway contributes to the reactive oxygen species generation and motility of small cell lung cancer cellsRamasamy Jagadeeswaran, Sujatha Jagadeeswaran, Vytas P Bindokas, et al.
Translational Oncology|June 6, 2026
Engineering nanozymes for cancer theranostics: Chemical design, catalytic intelligence, and translational oncology frontiersPankaj Garg, David Horne, Ravi Salgia, et al.
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|October 13, 2009
MET, HGF, EGFR, and PXN gene copy number in lung cancer using DNA extracts from FFPE archival samples and prognostic significanceRajani Kanteti, Soheil Yala, Mark K Ferguson, et al.
Neurology|January 30, 2013
Teaching Video NeuroImages: myokymia and nerve hyperexcitability as components of Morvan syndrome due to malignant thymomaRimas V Lukas, Kourosh Rezania, Monica Malec, et al.
Future Oncology (London, England)|February 19, 2016
Systemic therapies in the treatment of non-small-cell lung cancer brain metastasesRimas V Lukas, Priya Kumthekar, Syeda Rizvi, et al.
Cancer Metastasis Reviews|July 30, 2003
c-Met: structure, functions and potential for therapeutic inhibitionPatrick C Ma, Gautam Maulik, James Christensen, et al.
Frontiers in Pharmacology|January 24, 2022
Novel Therapeutic Targets and Immune Dysfunction in Malignant Pleural MesotheliomaMoshe Lapidot, Srinivas Vinod Saladi, Ravi Salgia, et al.
Trends in Molecular Medicine|July 23, 2019
The Mitochondrion as an Emerging Therapeutic Target in CancerKatherine G Roth, Isa Mambetsariev, Prakash Kulkarni, et al.
Trends in Cancer|March 2, 2021
Quantifying Cancer: More Than Just a Numbers GameRavi Salgia, Prakash Kulkarni, Herbert Levine, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Tumor Heterogeneity and Therapeutic ResistanceChristine M Lovly, April K S Salama, Ravi Salgia
Pageof 53